Chargement en cours...
Severe immune thrombocytopenia induced by nivolumab in a patient with metastatic renal cell carcinoma
In the Checkmate-025 trial, nivolumab treatment prolonged overall survival among patients with previously treated advanced renal cell carcinoma (RCC) compared with treatment with everolimus. Although effective, nivolumab is associated with immune-related adverse events (irAEs). However, the occurren...
Enregistré dans:
| Publié dans: | Urol Case Rep |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7256289/ https://ncbi.nlm.nih.gov/pubmed/32489885 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eucr.2020.101128 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|